Melanin synthesis and the action of L-dopa and 3,4-dihydroxybenzylamine in human melanoma cells E. P. W. KableP. G. Parsons Original Articles Pages: 1 - 7
The pharmacokinetics and toxicity of the anthrapyrazole anti-cancer drug CI-941 in the mouse: a guide for rational dose escalation in patients Martin A. GrahamDavid R. NewellA. Hilary Calvert Original Articles Pages: 8 - 14
Synthesis and antitumor activity of a series of (aminoethylpyrrolidine) platinum complexes Abdul R. KhokharDavid B. BrownMiles P. Hacker Original Articles Pages: 15 - 18
Association of sorcin with drug resistance in L1210 cells DeWayne RobertsMarian B. MeyersLee G. Wiggins Original Articles Pages: 19 - 25
Hydroxyurea potentiation of the antineoplastic activity of cyclophosphamide and 4′-(9-acridinylamino)methanesulfon-M-anisidide (AMSA) in the brown Norway rat myelocytic leukemia model William P. VaughanChris HolmKaey Cordel Original Articles Pages: 26 - 30
Regional chemotherapy in an experimental model of Wilms' tumor in rats Peter M. AndrewsClyde L. Johnson Jr Original Articles Pages: 31 - 36
Evaluation of the effect of furosemide on ultrafilterable platinum kinetics in patients treated with cis-diamminedichloroplatinum Monique DumasCatherine de GislainNicole Autissier Original Articles Pages: 37 - 40
Dominance of resistance to the alkylating agent 1,2:5,6-dianhydrogalactitol in P388 mouse lymphoma hybrid cells István PályiJudit BenceLehel Hullán Original Articles Pages: 41 - 46
A new irreversible aromatase inhibitor, 6-methylenandrosta-1,4-diene-3,17-dione (FCE 24304): antitumor activity and endocrine effects in rats with DMBA-induced mammary tumors T. ZaccheoD. GiudiciE. di Salle Original Articles Pages: 47 - 50
Phase II study of combination 4′-epidoxorubicin and mitomycin C in recurrent epithelial ovarian cancer Charles RedmanFrank LawtonGeorge Blackledge Original Articles Pages: 51 - 53
Phase II study of mitoxantrone in unresectable primary hepatocellular carcinoma following hepatitis B infection Kwok-Hung LaiYang-Te TsaiWing-Kai Chan Original Articles Pages: 54 - 56
Combination chemotherapy of cisplatin and 5-fluorouracil for advanced colorectal adenocarcinoma Nicholas J. PetrelliStephan MadejewiczArnold Mittelman Original Articles Pages: 57 - 60
Phase II trial of continuous-infusion iproplatin (CHIP) and 5-fluorouracil (5-FU) in advanced colorectal carcinoma Nicholas J. PetrelliPatrick J. CreavenArnold Mittelman Short Communication Pages: 61 - 62
